Former press secretary Karoline Leavitt lands her next gig: Fox News contributor - CTV News

Voices Kurt Bardella Cargo containers are stacked on a cargo ship moving through the Panama Canal. Exporters in the U. S. can suffer disproportionately when overseas markets seek to punish the Trump administration. (Matias Delacroix / Associated Press) By Kurt BardellaGuest contributor  Oct. 4, 2026 3:01 AM PT Click here to listen to this article See more from the L. A. Times in Google Search. Set us as preferred For half a century, Republicans have worn the “party of business” label like a permanent badge — tax cuts, deregulation, tough trade talk — while Democrats have too often ceded the ground, treating economic strength as someone else’s brand to react to rather than a story to tell. A new survey commissioned by the nonpartisan U. S.-Asia Fair Market Alliance hands Democrats a rare gift: hard data showing there is a genuine, winnable opening on economic fairness, and it maps precisely onto the values Democrats already claim. The numbers are hard to argue with. A poll of 1,000 nationally representative voters and 318 D.

By Jennifer Weiss-WolfGuest contributor  Oct. 3, 2026 3:03 AM PT Menopause has been having a moment lately, and Washington is taking notice. On Sept. 16, the Senate held its first hearing on the dismal state of federally funded menopause research and vast gaps in treatment and care. Within 24 hours, the Department of Health and Human Services also convened pharmaceutical manufacturers and physicians to troubleshoot the alarming lack of availability of estradiol patches, an essential menopause hormone treatment, and the Food and Drug Administration held a full day of expert panels on female-dosed testosterone, which is currently only FDA-approved for men. One week later, Health and Human Services joined the American Urological Assn. for a discussion about a silent killer of postmenopausal women: urosepsis from recurrent urinary tract infections. There is a simple solution — localized vaginal estrogen — and yet because of outdated guidelines and lack of clinician training, the medication is too often ignored or denied. Nor is the prescription routinely covered by Medicare, despite its well-established health and longevity benefits for women over age 65.